Comparison between Balaji Phosphates IPO and Nukleus Office Solutions IPO.
Balaji Phosphates IPO is a SME Fixed Price IPO proposed to list at NSE SME while Nukleus Office Solutions IPO is a SME Fixed Price proposed to list at BSE SME.
| Balaji Phosphates IPO | Nukleus Office Solutions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Arihant Capital Markets Ltd. | Sundae Capital Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Balaji Phosphates IPO is up to ₹47.60 Cr whereas the issue size of the Nukleus Office Solutions IPO is up to ₹23.67 Cr. The final issue price of Balaji Phosphates IPO is ₹70.00 per share and of Nukleus Office Solutions IPO is ₹234.00 per share.
| Balaji Phosphates IPO | Nukleus Office Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹66.00 per share | |
| Issue Price (Upper) | ₹70.00 per share | |
| Issue Price (Final) | ₹70.00 per share | ₹234.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 600 shares |
| Fresh Issue Size | 55,82,000 shares | 10,11,600 shares |
| Fresh Issue Size (Amount) | up to ₹39.07 Cr | up to ₹23.67 Cr |
| OFS Issue Size | 12,18,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹8.53 Cr | up to ₹0.00 Cr |
| Issue Size Total | 68,00,000 shares | 10,11,600 shares |
| Issue Size Total (Amount) | up to ₹47.60 Cr | up to ₹23.67 Cr |
Balaji Phosphates IPO opens on Feb 28, 2025, while Nukleus Office Solutions IPO opens on Feb 24, 2025. The closing date of Balaji Phosphates IPO and Nukleus Office Solutions IPO is Mar 04, 2025, and Feb 27, 2025, respectively.
| Balaji Phosphates IPO | Nukleus Office Solutions IPO | |
|---|---|---|
| Anchor Bid Date | Feb 27, 2025 | |
| Issue Open | Feb 28, 2025 | Feb 24, 2025 |
| Issue Close | Mar 04, 2025 | Feb 27, 2025 |
| Basis Of Allotment (Tentative) | Mar 05, 2025 | Feb 28, 2025 |
| Initiation of Refunds (Tentative) | Mar 06, 2025 | Mar 03, 2025 |
| Credit of Share (Tentative) | Mar 06, 2025 | Mar 03, 2025 |
| Listing date (Tentative) | Mar 07, 2025 | Mar 04, 2025 |
| Anchor Lockin End date 1 | Apr 04, 2025 | |
| Anchor Lockin End date 2 | Jun 03, 2025 |
Balaji Phosphates IPO P/E ratio is 20.67, as compared to Nukleus Office Solutions IPO P/E ratio of 52.33.
| Balaji Phosphates IPO | Nukleus Office Solutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Balaji Phosphates Limited Financial Information (Restated Consolidated)
| Nukleus Office Solutions Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.90 | 68.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.67 | 52.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹166.44 Cr. | ₹94.35 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 18.89% | 46.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 16.7% | 14.39% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.95 | 1.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.39 | ₹4.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 17.26% | 46.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Balaji Phosphates IPO Retail Individual Investors (RII) are offered 27,20,000 shares while in Nukleus Office Solutions IPO retail investors are offered 27,20,000 shares. Qualified Institutional Buyers (QIB) are offered 14,68,000 shares in Balaji Phosphates IPO and 0 shares in Nukleus Office Solutions IPO.
| Balaji Phosphates IPO | Nukleus Office Solutions IPO | |
|---|---|---|
| Anchor Investor Reserveration | 5,72,000 shares | 0 shares |
| Market Maker Reserveration | 3,58,000 shares | 53,400 shares |
| QIB | 14,68,000 shares | 0 shares |
| NII | 20,40,000 shares | 5,05,800 shares |
| RII | 27,20,000 shares | 5,05,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 68,00,000 shares | 10,11,600 shares |
Balaji Phosphates IPO subscribed 1.21x in total, whereas Nukleus Office Solutions IPO subscribed 1.29x.
| Balaji Phosphates IPO | Nukleus Office Solutions IPO | |
|---|---|---|
| QIB (times) | 1.26x | |
| NII (times) | 1.34x | 0.87x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.09x | 1.70x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.21x | 1.29x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
